Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Enzyme (MLN) Price & Performance

InjectiveTrade
EnzymeTrade

Price performance (Past 24H)

Key statistics

Injective vs Enzyme — how do they compare? Injective trades at Rp92,698 (market cap Rp9,18T, Rp1,72T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Injective is far larger — about 68441.1× Enzyme's market cap, and Injective's circulating supply is 100M INJ versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Enzyme for 28 Days on average.

INJMLN
Market Cap
Rp9,18TRp134,13M
Volume (24h)
Rp1,72TRp104,56M
Circulating Supply
100M INJ3,3M MLN
Typical Hold Time
36 Days28 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Enzyme

Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.

Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
MLN

No sentiment data available yet.

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN